The Janus-Face of Bacteriophages across Human Body Habitats

PLoS Pathogens

Volumn 12, Issue 6, 2016, Pages

  Wahida, Adam ^a   Ritter, Klaus ^a   Horz, Hans Peter ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BACTERIAL GENE; BACTERIAL VIRULENCE; BACTERIOPHAGE; COLON CROHN DISEASE; EPIFLUORESCENCE MICROSCOPY; HUMAN; METAGENOMICS; MICROBIAL COMMUNITY; MICROBIAL DIVERSITY; MICROBIOME; MICROFLORA; NONHUMAN; PERIODONTAL DISEASE; SPECIES HABITAT; ULCERATIVE COLITIS;

BACTERIOPHAGES; HUMANS; MICROBIOTA;

EID: 84978852403     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1005634     Document Type: Article

References (70)

1. Twort FW, An investigation on the nature of ultra-microscopic viruses. The Lancet. 1915;186: 1241–1243.
2. d’Herelle F, An invisible microbe that is antagonistic to the dysentery bacillus. Comptes Rendus Acad Sci Paris. 1917;165: 373–375.
3. Matsuzaki S, Rashel M, Uchiyama J, Sakurai S, Ujihara T, Kuroda M, et al. Bacteriophage therapy: a revitalized therapy against bacterial infectious diseases. J Infect Chemother. 2005;11: 211–219. doi: 10.1007/s10156-005-0408-916258815
4. Boucher HW, Talbot GH, Bradley JS, Edwards JE, Gilbert D, Rice LB, et al. Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America. Clin Infect Dis. 2009;48: 1–12. doi: 10.1086/59501119035777
5. Viertel TM, Ritter K, Horz H-P, Viruses versus bacteria—novel approaches to phage therapy as a tool against multidrug-resistant pathogens. J Antimicrob Chemother. 2014;69: 2326–2336. doi: 10.1093/jac/dku17324872344
6. De Paepe M, Leclerc M, Tinsley CR, Petit M-A, Bacteriophages: an underestimated role in human and animal health?Front Cell Infect Microbiol. 2014;4. doi: 10.3389/fcimb.2014.00039
7. Rasko DA, Webster DR, Sahl JW, Bashir A, Boisen N, Scheutz F, et al. Origins of the E. coli strain causing an outbreak of hemolytic–uremic syndrome in Germany. N Engl J Med. 2011;365: 709–717. doi: 10.1056/NEJMoa110692021793740
8. Penadés JR, Chen J, Quiles-Puchalt N, Carpena N, Novick RP, Bacteriophage-mediated spread of bacterial virulence genes. Curr Opin Microbiol. 2015;23: 171–178. doi: 10.1016/j.mib.2014.11.01925528295
9. Dalmasso M, Hill C, Ross RP, Exploiting gut bacteriophages for human health. Trends Microbiol. 2014;22: 399–405. doi: 10.1016/j.tim.2014.02.01024656964
10. Huttenhower C, Gevers D, Knight R, Abubucker S, Badger JH, Chinwalla AT, et al. Structure, function and diversity of the healthy human microbiome. Nature. 2012;486: 207–214. doi: 10.1038/nature1123422699609
11. Li K, Bihan M, Yooseph S, Methe BA, Analyses of the microbial diversity across the human microbiome. PLoS ONE. 2012;7: e32118. doi: 10.1371/journal.pone.003211822719823
12. Virgin HW, The Virome in Mammalian Physiology and Disease. Cell. 2014;157: 142–150. doi: 10.1016/j.cell.2014.02.03224679532
13. Wylie KM, Weinstock GM, Storch GA, Emerging view of the human virome. Transl Res. 2012;160: 283–290. doi: 10.1016/j.trsl.2012.03.00622683423
14. Reyes A, Semenkovich NP, Whiteson K, Rohwer F, Gordon JI, Going viral: next-generation sequencing applied to phage populations in the human gut. Nat Rev Microbiol. 2012;10: 607–617. doi: 10.1038/nrmicro285322864264
15. Rodriguez-Valera F, Martin-Cuadrado A-B, Rodriguez-Brito B, Pašić L, Thingstad TF, Rohwer F, et al. Explaining microbial population genomics through phage predation. Nat Rev Microbiol. 2009;7: 828–836. doi: 10.1038/nrmicro223519834481
16. Bik EM, Long CD, Armitage GC, Loomer P, Emerson J, Mongodin EF, et al. Bacterial diversity in the oral cavity of 10 healthy individuals. ISME J. 2010;4: 962–974. doi: 10.1038/ismej.2010.3020336157
17. Bachrach G, Leizerovici-Zigmond M, Zlotkin A, Naor R, Steinberg D, Bacteriophage isolation from human saliva. Lett Appl Microbiol. 2003;36: 50–53. 12485342
18. Hitch G, Pratten J, Taylor PW, Isolation of bacteriophages from the oral cavity. Lett Appl Microbiol. 2004;39: 215–219. doi: 10.1111/j.1472-765X.2004.01565.x15242464
19. Pride DT, Salzman J, Haynes M, Rohwer F, Davis-Long C, White RA, et al. Evidence of a robust resident bacteriophage population revealed through analysis of the human salivary virome. ISME J. 2012;6: 915–926. doi: 10.1038/ismej.2011.16922158393
20. Willner D, Furlan M, Schmieder R, Grasis JA, Pride DT, Relman DA, et al. Metagenomic detection of phage-encoded platelet-binding factors in the human oral cavity. Proc Natl Acad Sci. 2011;108: 4547–4553. doi: 10.1073/pnas.100008910720547834
21. Abeles SR, Robles-Sikisaka R, Ly M, Lum AG, Salzman J, Boehm TK, et al. Human oral viruses are personal, persistent and gender-consistent. ISME J. 2014;8: 1753–1767. doi: 10.1038/ismej.2014.3124646696
22. Abeles SR, Pride DT, Molecular Bases and Role of Viruses in the Human Microbiome. J Mol Biol. 2014;426: 3892–3906. doi: 10.1016/j.jmb.2014.07.00225020228
23. Ly M, Abeles SR, Boehm TK, Robles-Sikisaka R, Naidu M, Santiago-Rodriguez T, et al. Altered Oral Viral Ecology in Association with Periodontal Disease. mBio. 2014;5: e01133–14. doi: 10.1128/mBio.01133-1424846382
24. Santiago-Rodriguez TM, Naidu M, Abeles SR, Boehm TK, Ly M, Pride DT, Transcriptome analysis of bacteriophage communities in periodontal health and disease. BMC Genomics. 2015;16. doi: 10.1186/s12864-015-1781-0
25. Edlund A, Santiago-Rodriguez TM, Boehm TK, Pride DT, Bacteriophage and their potential roles in the human oral cavity. J Oral Microbiol. 2015;7. doi: 10.3402/jom.v7.27423
26. Wang J, Gao Y, Zhao F, Phage-bacteria interaction network in human oral microbiome: Human oral virome. Environ Microbiol. 2015; n/a–n/a. doi: 10.1111/1462-2920.12923
27. Gill SR, Pop M, DeBoy RT, Eckburg PB, Turnbaugh PJ, Samuel BS, et al. Metagenomic Analysis of the Human Distal Gut Microbiome. Science. 2006;312: 1355–1359. doi: 10.1126/science.112423416741115
28. Lepage P, Leclerc MC, Joossens M, Mondot S, Blottiere HM, Raes J, et al. A metagenomic insight into our gut’s microbiome. Gut. 2013;62: 146–158. doi: 10.1136/gutjnl-2011-30180522525886
29. Heijtz RD, Wang S, Anuar F, Qian Y, Bjorkholm B, Samuelsson A, et al. Normal gut microbiota modulates brain development and behavior. Proc Natl Acad Sci. 2011;108: 3047–3052. doi: 10.1073/pnas.101052910821282636
30. Hur KY, Lee M-S, Gut Microbiota and Metabolic Disorders. Diabetes Metab J. 2015;39: 198. doi: 10.4093/dmj.2015.39.3.19826124989
31. Kirpich IA, Marsano LS, McClain CJ, Gut–liver axis, nutrition, and non-alcoholic fatty liver disease. Clin Biochem. 2015; doi: 10.1016/j.clinbiochem.2015.06.023
32. van Best N, Jansen PL, Rensen SS, The gut microbiota of nonalcoholic fatty liver disease: current methods and their interpretation. Hepatol Int. 2015;9: 406–415. doi: 10.1007/s12072-015-9640-226067771
33. Waller AS, Yamada T, Kristensen DM, Kultima JR, Sunagawa S, Koonin EV, et al. Classification and quantification of bacteriophage taxa in human gut metagenomes. ISME J. 2014;8: 1391–1402. doi: 10.1038/ismej.2014.3024621522
34. Barr JJ, Auro R, Furlan M, Whiteson KL, Erb ML, Pogliano J, et al. Bacteriophage adhering to mucus provide a non–host-derived immunity. Proc Natl Acad Sci. 2013;110: 10771–10776. doi: 10.1073/pnas.130592311023690590
35. Duerkop BA, Hooper LV, Resident viruses and their interactions with the immune system. Nat Immunol. 2013;14: 654–659. doi: 10.1038/ni.261423778792
36. Barr JJ, Youle M, Rohwer F, Innate and acquired bacteriophage-mediated immunity. Bacteriophage. 2013;3: e25857. doi: 10.4161/bact.2585724228227
37. Baker PI, Love DR, Ferguson LR, Role of gut microbiota in Crohn’s disease. Expert Rev Gastroenterol Hepatol. 2009;3: 535–546. doi: 10.1586/egh.09.4719817674
38. Lepage P, Colombet J, Marteau P, Sime-Ngando T, Doré J, Leclerc M, Dysbiosis in inflammatory bowel disease: a role for bacteriophages?Gut. 2008;57: 424–425. doi: 10.1136/gut.2007.13466818268057
39. Pérez-Brocal V, García-López R, Vázquez-Castellanos JF, Nos P, Beltrán B, Latorre A, et al. Study of the Viral and Microbial Communities Associated With Crohn’s Disease: A Metagenomic Approach. Clin Transl Gastroenterol. 2013;4: e36. doi: 10.1038/ctg.2013.923760301
40. Norman JM, Handley SA, Baldridge MT, Droit L, Liu CY, Keller BC, et al. Disease-Specific Alterations in the Enteric Virome in Inflammatory Bowel Disease. Cell. 2015;160: 447–460. doi: 10.1016/j.cell.2015.01.00225619688
41. van Nood E, Vrieze A, Nieuwdorp M, Fuentes S, Zoetendal EG, de Vos WM, et al. Duodenal Infusion of Donor Feces for Recurrent Clostridium difficile. N Engl J Med. 2013;368: 407–415. doi: 10.1056/NEJMoa120503723323867
42. Ventura M, Sozzi T, Turroni F, Matteuzzi D, van Sinderen D, The impact of bacteriophages on probiotic bacteria and gut microbiota diversity. Genes Nutr. 2011;6: 205–207. doi: 10.1007/s12263-010-0188-421484155
43. Modi SR, Lee HH, Spina CS, Collins JJ, Antibiotic treatment expands the resistance reservoir and ecological network of the phage metagenome. Nature. 2013;499: 219–222. doi: 10.1038/nature1221223748443
44. Dethlefsen L, Huse S, Sogin ML, Relman DA, Eisen JA, The Pervasive Effects of an Antibiotic on the Human Gut Microbiota, as Revealed by Deep 16S rRNA Sequencing. PLoS Biol. 2008;6: e280. doi: 10.1371/journal.pbio.006028019018661
45. Butler BC, Beakley JW, Bacterial flora in vaginitis: a study before and after treatment with pure cultures of Doederlein bacillus. Am J Obstet Gynecol. 1960;79: 432–440. 13806471
46. Srinivasan S, Fredricks DN, The Human Vaginal Bacterial Biota and Bacterial Vaginosis. Interdiscip Perspect Infect Dis. 2008;2008: 1–22. doi: 10.1155/2008/750479
47. Eckert LO, Acute vulvovaginitis. N Engl J Med. 2006;355: 1244–1252. 16990387
48. Graver MA, Wade JJ, The role of acidification in the inhibition of Neisseria gonorrhoeae by vaginal lactobacilli during anaerobic growth. Ann Clin Microbiol Antimicrob. 2011;10: 8. doi: 10.1186/1476-0711-10-821329492
49. Witkin SS, Linhares IM, Giraldo P, Bacterial flora of the female genital tract: function and immune regulation. Best Pract Res Clin Obstet Gynaecol. 2007;21: 347–354. doi: 10.1016/j.bpobgyn.2006.12.00417215167
50. Turovskiy Y, Sutyak Noll K, Chikindas M l, The aetiology of bacterial vaginosis. J Appl Microbiol. 2011;110: 1105–1128. doi: 10.1111/j.1365-2672.2011.04977.x21332897
51. Kilic AO, Pavlova SI, Alpay S, Kilic SS, Tao L, Comparative Study of Vaginal Lactobacillus Phages Isolated from Women in the United States and Turkey: Prevalence, Morphology, Host Range, and DNA Homology. Clin Vaccine Immunol. 2001;8: 31–39. doi: 10.1128/CDLI.8.1.31–39.2001
52. Pavlova SI, Kiliç AO, Mou SM, Tao L, Phage infection in vaginal lactobacilli: an in vitro study. Infect Dis Obstet Gynecol. 1997;5: 36–44. 18476132
53. Melikian AA, Sun P, Prokopczyk B, El-Bayoumy K, Hoffmann D, Wang X, et al. Identification of benzo [a] pyrene metabolites in cervical mucus and DNA adducts in cervical tissues in humans by gas chromatography-mass spectrometry. Cancer Lett. 1999;146: 127–134. 10656617
54. Pavlova SI, Tao L, Induction of vaginal Lactobacillus phages by the cigarette smoke chemical benzo [a] pyrene diol epoxide. Mutat Res Toxicol Environ Mutagen. 2000;466: 57–62.
55. Gao Z, Perez-Perez GI, Chen Y, Blaser MJ, Quantitation of Major Human Cutaneous Bacterial and Fungal Populations. J Clin Microbiol. 2010;48: 3575–3581. doi: 10.1128/JCM.00597-1020702672
56. Gao Z, Tseng C, Pei Z, Blaser MJ, Molecular analysis of human forearm superficial skin bacterial biota. Proc Natl Acad Sci. 2007;104: 2927–2932. 17293459
57. Grice EA, Kong HH, Conlan S, Deming CB, Davis J, Young AC, et al. Topographical and Temporal Diversity of the Human Skin Microbiome. Science. 2009;324: 1190–1192. doi: 10.1126/science.117170019478181
58. Nakatsuji T, Chiang H-I, Jiang SB, Nagarajan H, Zengler K, Gallo RL, The microbiome extends to subepidermal compartments of normal skin. Nat Commun. 2013;4: 1431. doi: 10.1038/ncomms244123385576
59. Probst AJ, Auerbach AK, Moissl-Eichinger C, Neufeld J, Archaea on Human Skin. PLoS ONE. 2013;8: e65388. doi: 10.1371/journal.pone.006538823776475
60. Liu J, Yan R, Zhong Q, Ngo S, Bangayan NJ, Nguyen L, et al. The diversity and host interactions of Propionibacterium acnes bacteriophages on human skin. ISME J. 2015; http://www.nature.com/ismej/journal/vaop/ncurrent/full/ismej201547a.html
61. Oh J, Byrd AL, Deming C, Conlan S, Barnabas B, Blakesley R, et al. Biogeography and individuality shape function in the human skin metagenome. Nature. 2014;514: 59–64. doi: 10.1038/nature1378625279917
62. Marinelli LJ, Fitz-Gibbon S, Hayes C, Bowman C, Inkeles M, Loncaric A, et al. Propionibacterium acnes Bacteriophages Display Limited Genetic Diversity and Broad Killing Activity against Bacterial Skin Isolates. mBio. 2012;3: e00279–12–e00279–12. doi: 10.1128/mBio.00279-12
63. Brüggemann H, Lood R, Bacteriophages Infecting Propionibacterium acnes. BioMed Res Int. 2013;2013: 1–10. doi: 10.1155/2013/705741
64. Dashiff A, Junka RA, Libera M, Kadouri DE, Predation of human pathogens by the predatory bacteria Micavibrio aeruginosavorus and Bdellovibrio bacteriovorus: Predation by M. aeruginosavorus and B. bacteriovorus. J Appl Microbiol. 2011;110: 431–444. doi: 10.1111/j.1365-2672.2010.04900.x21114596
65. Mojsoska B, Jenssen H, Peptides and Peptidomimetics for Antimicrobial Drug Design. Pharmaceuticals. 2015;8: 366–415. doi: 10.3390/ph803036626184232
66. Nobrega FL, Costa AR, Kluskens LD, Azeredo J, Revisiting phage therapy: new applications for old resources. Trends Microbiol. 2015;23: 185–191. doi: 10.1016/j.tim.2015.01.00625708933
67. Brüssow H, What is needed for phage therapy to become a reality in Western medicine?Virology. 2012;434: 138–142. doi: 10.1016/j.virol.2012.09.01523059181
68. Pirnay J-P, Blasdel BG, Bretaudeau L, Buckling A, Chanishvili N, Clark JR, et al. Quality and Safety Requirements for Sustainable Phage Therapy Products. Pharm Res. 2015;32: 2173–2179. doi: 10.1007/s11095-014-1617-725585954
69. Pirnay J-P, De Vos D, Verbeken G, Merabishvili M, Chanishvili N, Vaneechoutte M, et al. The Phage Therapy Paradigm: Prêt-à-Porter or Sur-mesure?Pharm Res. 2011;28: 934–937. doi: 10.1007/s11095-010-0313-521063753
70. Verbeken G, De Vos D, Vaneechoutte M, Merabishvili M, Zizi M, Pirnay J-P, European regulatory conundrum of phage therapy. Future Microbiol. 2007;2: 485–491. doi: 10.2217/17460913.2.5.48517927471